{
  "id": 3620,
  "text": "1612.Rose, P.G., Blessing, J.A.& Arseneau, J.Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.Gynecol Oncol 62, 100-102 (1996).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1612.Rose, P.G., Blessing, J.A.& Arseneau, J.Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.Gynecol Oncol 62, 100-102 (1996).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "altretamine 曾作为药物在晚期或复发性鳞状细胞宫颈癌患者中进行研究评估。根据研究结果，这种药物在这个特定癌症的治疗中进行了二期评估，属于妇科肿瘤研究的一部分。该研究旨在探索 altretamine 的有效性和安全性，以期为晚期或复发性鳞状细胞宫颈癌的治疗提供新的可能性。",
  "query": "根据提供的 <text>，内容确实与宫颈癌相关，因此不会回应 \"SKIP\"。以下是一个与该内容对齐的问题：\n\n在研究晚期或复发性鳞状细胞宫颈癌的治疗方法时，altretamine 是否曾被作为一项研究药物进行评估？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据提供的 <text>，内容确实与宫颈癌相关，因此不会回应 \"SKIP\"。以下是一个与该内容对齐的问题：\n\n在研究晚期或复发性鳞状细胞宫颈癌的治疗方法时，altretamine 是否曾被作为一项研究药物进行评估？\n\n<reference text>: 1612.Rose, P.G., Blessing, J.A.& Arseneau, J.Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.Gynecol Oncol 62, 100-102 (1996).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "altretamine 曾作为药物在晚期或复发性鳞状细胞宫颈癌患者中进行研究评估。根据研究结果，这种药物在这个特定癌症的治疗中进行了二期评估，属于妇科肿瘤研究的一部分。该研究旨在探索 altretamine 的有效性和安全性，以期为晚期或复发性鳞状细胞宫颈癌的治疗提供新的可能性。"
}